Viruses

Open AccessCommentary

Primed for Discovery: Atomic-Resolution Cryo-EM Structure of a Reovirus Entry Intermediate

by

Shane D. Trask

,

Kristen M. Guglielmi

and

John T. Patton

Viruses 2010, 2(6), 1340-1346; https://doi.org/10.3390/v2061340 - 15 Jun 2010

Cited by 1 | Viewed by 9187

Abstract

A recently solved structure of the aquareovirus virion (Zhang, X; Jin, L.; Fang, Q; Hui, W.H.; Zhou Z.H. 3.3 Å Cryo-EM Structure of a Nonenveloped Virus Reveals a Priming Mechanism for Cell Entry. Cell 2010, 141, 472-482 [1]) provides new insights [...] Read more.

A recently solved structure of the aquareovirus virion (Zhang, X; Jin, L.; Fang, Q; Hui, W.H.; Zhou Z.H. 3.3 Å Cryo-EM Structure of a Nonenveloped Virus Reveals a Priming Mechanism for Cell Entry. Cell 2010, 141, 472-482 [1]) provides new insights into the order of entry events, as well as confirming and refining several aspects of the entry mechanism, for aquareovirus and the related orthoreovirus. In particular, the structure provides evidence of a defined order for the progressive proteolytic cleavages of myristoylated penetration protein VP5 that prime the virion for membrane penetration. These observations reinforce the concept that, much like enveloped viruses, nonenveloped virions often undergo priming events that lead to a meta-stable state, preparing the virus for membrane penetration under the appropriate circumstances. In addition, this and other recent studies highlight the increasing power of electron cryomicroscopy to analyze large, geometrically regular structures, such as icosahedral viruses, at atomic resolution. Full article

► Show Figures

Figure 1

Open AccessReview

Historical Perspectives in the Development of Antiviral Agents Against Poxviruses

by

Erik De Clercq

Viruses 2010, 2(6), 1322-1339; https://doi.org/10.3390/v2061322 - 14 Jun 2010

Cited by 29 | Viewed by 9088

Abstract

The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the chemotherapy or -prophylaxis of poxvirus [...] Read more.

The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the chemotherapy or -prophylaxis of poxvirus infections, numerous candidate compounds have been described over the past 50 years. These compounds include interferon and inducers thereof (i.e., polyacrylic acid), 5-substituted 2’-deoxyuridines (i.e., idoxuridine), IMP dehydrogenase inhibitors, S-adenosylhomocysteine hydrolase inhibitors, acyclic nucleoside phosphonates (such as cidofovir) and alkoxyalkyl prodrugs thereof (such as CMX001), viral egress inhibitors (such as tecovirimat), and cellular kinase inhibitors (such as imatinib). Full article

(This article belongs to the Special Issue Antivirals Against Poxviruses)

► Show Figures

Figure 1

Open AccessReview

Cell-to-Cell Spread of Retroviruses

by

Quentin J. Sattentau

Viruses 2010, 2(6), 1306-1321; https://doi.org/10.3390/v2061306 - 10 Jun 2010

Cited by 96 | Viewed by 12381

Abstract

Viruses from several families use direct cell-to-cell infection to disseminate between cells. Retroviruses are a relatively recent addition to this list, and appear to spread cell-to-cell by induction of multimolecular complexes termed virological synapses that assemble at the interface between infected and receptor-expressing [...] Read more.

Viruses from several families use direct cell-to-cell infection to disseminate between cells. Retroviruses are a relatively recent addition to this list, and appear to spread cell-to-cell by induction of multimolecular complexes termed virological synapses that assemble at the interface between infected and receptor-expressing target cells. Over the past five years, detailed insight into the cellular and molecular basis of virological synapse-mediated retroviral cell-to-cell spread has been obtained, but important questions and controversies have been raised that remain to be resolved. This review will focus on recent advances in the field with emphasis on areas in which work still needs to be done. Full article

(This article belongs to the Special Issue Transmission of Retroviruses across Virological Synapses)

► Show Figures

Graphical abstract

Open AccessReview

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

by Erik De Clercq,

Geoffrey Férir

,

Suzanne Kaptein

and

Johan Neyts

Viruses 2010, 2(6), 1279-1305; https://doi.org/10.3390/v2061279 - 31 May 2010

Cited by 47 | Viewed by 14129

Abstract

While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudine and tenofovir (disoproxil fumarate). [...] Read more.

While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudine and tenofovir (disoproxil fumarate). In contrast to the treatment of HIV infections where the individual drugs are routinely used in combination, for the treatment of chronic HBV infection the individual drugs are generally used in monotherapy. In principle, combination drug therapy should allow reducing the likelihood of drug-resistant development. Full article

(This article belongs to the Special Issue Hepatitis Viruses)

► Show Figures

Figure 1

Open AccessReview

T Cell Polarization at the Virological Synapse

by

Clare Jolly

Viruses 2010, 2(6), 1261-1278; https://doi.org/10.3390/v2061261 - 31 May 2010

Cited by 21 | Viewed by 10195

Abstract

Cell-to-cell spread of HIV-1 between CD4⁺ T cells takes place at multimolecular structures called virological synapses. A defining feature of the virological synapse is polarization of viral assembly and budding at sites of T cell-T cell contact. Recent work is beginning to [...] Read more.

Cell-to-cell spread of HIV-1 between CD4⁺ T cells takes place at multimolecular structures called virological synapses. A defining feature of the virological synapse is polarization of viral assembly and budding at sites of T cell-T cell contact. Recent work is beginning to address how viral proteins are targeted to the virological synapse and the molecular mechanisms that regulate HIV-1 egress by cell-to-cell spread. This review discusses our current understanding of these processes and considers how T cell polarization during other forms of intercellular communication may provide insight into HIV-1 assembly and dissemination. Full article

(This article belongs to the Special Issue Transmission of Retroviruses across Virological Synapses)

► Show Figures

Figure 1

Journal Menu

Journal Browser

Viruses, Volume 2, Issue 6 (June 2010) – 5 articles , Pages 1261-1346

Further Information

Guidelines

MDPI Initiatives

Follow MDPI